Try our beta test site
316 studies found for:    Open Studies | "Kidney Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer
Conditions: Prostate Cancer;   Renal Cancer
Intervention: Drug: [68Ga]P16-093
22 Recruiting Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Conditions: Renal Cancer;   Chromophobe Renal Cell Carcinoma;   Birt-Hogg-Dube Syndrome
Intervention: Drug: Everolimus
23 Recruiting Off Clamp Randomization
Conditions: Renal Cancer;   Renal Ischemia
Intervention: Procedure: Off-clamp partial nephrectomy
24 Recruiting Safety and Feasibility of IRE for SRMs
Condition: Kidney Cancer
Intervention: Device: Irreversible Electroporation
25 Recruiting Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method
Conditions: Arrhythmia, Cardiac;   Kidney Cancer;   Surgery;   Anesthesia, Local
Interventions: Procedure: Epidural anesthesia;   Device: Holter ECG monitor;   Procedure: Open kidney cancer surgery;   Procedure: General anesthesia
26 Recruiting Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
Condition: Advanced Non-Clear Cell Kidney Cancer
Interventions: Drug: Bevacizumab;   Drug: Atezolizumab
27 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
28 Recruiting PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
Condition: Metastatic Renal Cancer
Intervention: Drug: Prednisone + Everolimus
29 Recruiting Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer
Condition: Renal Cell Carcinoma
Interventions: Biological: High Dose IL-2;   Radiation: SBRT
30 Recruiting Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
Condition: Renal Cancer
Interventions: Behavioral: (EORTC QLQ-C30) questionnaire;   Behavioral: EuroQol EQ-5D 7-item questionnaire
31 Recruiting Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
Conditions: Clear Cell Renal Cancer;   Circulating Tumor Cells;   Circulating Endothelial Cells;   Prognostic Biomarkers;   Predictive Biomarkers
Intervention: Other: None- observational study
32 Recruiting Active Surveillance of the Small Renal Mass
Condition: Small Renal Mass, Kidney Cancer
Intervention:
33 Not yet recruiting Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment
Condition: Clear Cell Renal Carcinoma
Intervention: Drug: Sunitinib
34 Recruiting Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Condition: Metastatic Renal Cancer
Intervention: Other: Biological samples
35 Recruiting Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma
Conditions: Kidney Neoplasms;   Metastatic Renal Cell Cancer
Intervention: Drug: Sunitinib
36 Recruiting IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)
Conditions: Clear-cell Metastatic Renal Cell Carcinoma;   Kidney Neoplasms
Intervention: Procedure: Molecular imaging
37 Recruiting Pilot Study of Presurgical Tremelimumab With or Without Cryoablation in Patients With Metastatic Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Tremelimumab;   Procedure: Cryoablation;   Behavioral: Long-Term Follow-Up
38 Recruiting Nivolumab vs Nivolumab + Bevacizumab vs Nivolumab + Ipilimumab in Metastatic Renal Cell Carcinoma (mRCC)
Condition: Kidney Cancer
Interventions: Drug: Nivolumab;   Drug: Bevacizumab;   Drug: Ipilimumab
39 Recruiting Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Pazopanib;   Drug: Temsirolimus;   Behavioral: Quality of Life Assessment;   Drug: Benadryl
40 Recruiting Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer
Conditions: Recurrent Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Nephrectomy;   Biological: Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.